PRELUDE CAPITAL MANAGEMENT, LLC - ADAGIO THERAPEUTICS INC ownership

ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 77 filers reported holding ADAGIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ADAGIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$30,370
-57.8%
25,308
+16.1%
0.00%0.0%
Q2 2022$72,00021,8000.00%
Other shareholders
ADAGIO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 9,248,250$9,710,66312.83%
Alphabet Inc. 5,680,785$5,964,8240.32%
683 Capital Management, LLC 4,000,000$4,200,0000.30%
Bain Capital Life Sciences Investors, LLC 1,937,207$2,034,0670.21%
TANG CAPITAL MANAGEMENT LLC 1,151,843$1,209,4350.18%
Slate Path Capital LP 3,735,000$3,921,7500.14%
BML Capital Management, LLC 134,696$141,4310.13%
Orbimed Advisors 5,270,400$5,533,9200.10%
Redmile Group, LLC 1,440,725$1,512,7610.06%
MAVERICK CAPITAL LTD 2,338,373$2,455,2920.05%
View complete list of ADAGIO THERAPEUTICS INC shareholders